Like the laboratory parameters of cancer patients with COVID-19, the median expression levels of CRP, mg/L (10.95, IQR [1.55–43.18]), and IL-6, pg/ml (12.30, IQR [5.48–28.22]) in COVID-19 patients without cancer were significantly higher than the upper limit of the normal reference range. This evidence concerns the gene IL6 and cancer.